Focal cerebral infarction and edema were measured in rats (Wi star, Fisher 344, and spontaneously hypertensive strains) pretreated with nimodipine (2 I-Lg/kg/min i.v.) or its vehicle and subjected to the tandem occlusion of the middle cerebral and common carotid ar teries. Animals awoke from anesthesia 10--15 min after onset of ischemia and continued to receive treatment over a 24-h survival period. Cortical infarction and edema were quantified by image analysis of frozen brain sections processed for histology. Nimodipine-treated rats devel oped 20--60% smaller cortical infarct volumes than con-
There is growing evidence that pretreatment with nimodipine, a calcium channel blocker and potent cerebral vasodilator, can protect against focal cere bral ischemic damage. If administered before the experimental induction of focal cerebral ischemia, nimodipine has been shown to increase residual CBF in the ischemic bed, ameliorate local acidosis (Meyer et aI., 1988) , and reduce the extent of his tologic damage (Mohamed et aI., 1985a ) measured 4 h after onset of ischemia. Clinically, the number of ischemic strokes complicating aneurysmal sub arachnoid hemorrhage has been consistently re duced by nimodipine pretreatment (Allen et aI., 1983; Auer, 1984 , Philippon et aI., 1986 Brandt et aI., 1988; Jan et aI., 1988; Ohman and Heiskanen, 1988; Petruk et aI., 1988; Pickard et aI., 1989) . This evidence notwithstanding, the clinical acceptance troIs (p < 0.002). Cortical edema was reduced proportion ately to the decrease in infarct volume and constituted -36% of the infarct volume. Nimodipine caused a mild hypotensive response that did not aggravate ischemic brain damage. The results indicate that continuous nimo dipine treatment, started before induction of focal cere bral ischemia, can attenuate ischemic brain damage and edema as late as 24 h after the onset of ischemia. Key Words: Calcium channel blocker-Focal cerebral isch emia-Middle cerebral artery occlusion-Nimodipine Spontaneously hypertensive rat.
of nimodipine in threatened ischemic stroke has been hampered by concerns that benefit could be offset by (a) nimodipine-induced hypotension (Mo hamed et aI., 1984) , (b) cerebrodilator therapy shunting blood from ischemic to nonischemic re gions (Olesen and Paulson, 1971) , and (c) nimo dipine accelerating edema formation as CBF in creases in regions with a disrupted blood-brain bar rier (Harris et aI., 1982) . Moreover, the histologic protection offered by nimodipine pretreatment may be modest (Mohamed et aI., 1985a) , and with per sistent ischemia the early benefit could succumb to a progressively cytotoxic environment. The latter possibility, however, has not been experimentally tested.
The current study examines the late effect (i.e., 24 h after ischemia onset) of continuous nimodipine treatment, started before onset of the ischemic event, on cortical infarction and edema in rats sub jected to permanent middle cerebral (MCA) and common carotid (CCA) artery occlusion (MCAI CCAO). The importance of nimodipine-induced hy potension on infarct size is addressed.
METHODS
The present study was conducted concurrently with efforts to establish a focal stroke model that offered the largest and most reproducible infarct volume in the adult male rat (Brint et ai., 1988) . The right MCA and CCA were occluded in tandem to produce graded, focal corti cal ischemia and progressive infarction in the territory of the MCA (Jacewicz et ai., 1986; Brint et ai., 1988) . Over a 3-year period, nimodipine testing employed 96 rats (three rat strains) among six experimental groups: Wi star (WI, W2, and W3), Fisher 344 (Fl), and spontaneously hypertensive rats (SHRI and SHR2). Minor modifica tions in experimental design across groups are summa rized in Table 1 .
Surgery was divided into a lengthy preparative phase and a brief MCAICCAO phase to avoid the complications of prolonged anesthesia (see Discussion) and to hasten awakening once ischemia was induced. Preparative sur gery (60-min duration) involved the placement of a loose carotid artery ligature, arterial and venous catheters, and the Alzet microosmotic drug delivery system (see below). Animals typically awoke 30 min later. There followed a recovery period of either 2 (WI-3 and F1) or 24 h (SHRI and 2) ( Table 1) to permit measurement of baseline phys iologic variables in fully awake animals. The MCAICCAO procedure (20-to 30-min duration) ended with carotid li gation and MCA electrocauterization, following which halothane was immediately discontinued; animals awoke -15 min later.
Preparative surgery
Adult male rats (240-330 g; WI-3 and Fl, Hilltop Farms; SHRI and 2, Charles River) were anesthetized with 2% halothane in a mixture of 70% nitrogenl30% ox ygen. Surgical fields were shaved and washed with Pov idone iodine. The tail artery was catheterized (PE-50) for blood pressure monitoring and blood sampling. In some animals, anesthesia was then briefly interrupted (30 min) for the recording of awake (baseline) blood pressure (W2, W3, F1) and physiologic variables (W3). SHRI and 2 had baseline measurements taken on the following day. Via a right paramedian cervical incision, a loose ligature (4-0 silk) was placed around the right CCA. An Alzet microos motic pump (filled with 0.9% saline) was implanted sub cutaneously (1 j.Ll/h pumping rate for WI; 10 1 . .J/h for all other groups) (Theeuwes and Yum, 1976; Urquhart et ai., 1984) and attached via subcutaneous tubing (PE-90) to an external jugular or femoral vein. Anesthesia was discon tinued, and nimodipine or vehicle treatment (see below) was started in WI-3 and Fl. SHRI and 2 animals awoke and equilibrated overnight (to further distance the isch emic interval from the anesthesia of preparative surgery) before treatment.
Nimodipine (courtesy of Miles Laboratory) was dis solved in 3% ethanollPEG-400 (WI) or in PEG-400 (all other groups) for intravenous infusion at a rate of 2 j.Lg/kg/min. Because the small amount of ethanol in the vehicle (3% delivered at 1 j.Ll/h over 24 h) could have potentially affected cerebrovascular tone, autoregulation, and CBF (Goldman and Sapirstein, 1973; McQueen et ai., 1978; Altura et aI., 1983) , ethanol was later eliminated from the vehicle. Instead, nimodipine was dissolved in a larger volume of PEG-400 and delivered at a higher mi croosmotic pump rate (10 j.Ll/h) ( Table 1 ). All animals were fasted overnight piror to receiving nimodipine or vehicle. Two (WI-3 and F1) or twenty-four (SHRI and 2) hours after preparatory surgery, treatment was initiated by displacing the 0.9% saline in the tubing (via a detach able external connection) with a 24-to 30-h supply of nimodipine or vehicle. An hour after preparative surgery, the animals were alert and able to drink water and groom themselves. Drug delivery and physiological equilibration continued for 2 h prior to starting MCAICCAO surgery.
MCAICCAO
The right MCA was occluded by a transtemporal ap proach under light halothane anesthesia (Brint et ai., 1988) . Mechanical ventilation (Harvard Instruments) (WI and W2) became unnecessary when sufficient experience permitted rapid MCA/CCAO (20-30 min) that minimized CO2 retention and arterial acidosis. After partly removing the temporalis muscle, a 2-mm burr hole was drilled 2-3 mm rostral to the fusion of the zygoma with the squamo sal bone. All drilling was done under a continuous gentle flow of physiological saline (0.9%) to avoid heating of the underlying cortex. After the right common carotid liga ture was tightened, the dura was pierced to expose the MCA 0-1 mm above the rhinal fissure. The artery was gently lifted 1 mm off the cortical surface either by a 20-gauge silver wire hook (WI, W2, and F1) or by a 80-j.Lm stainless-steel hook (W3, SHRl, and SHR2). Ap plication of electrocautery (Geiger) to the hook severed the artery. Halothane was discontinued immediately to a To solubilize nimodipine in the absence of ethanol (all groups but WI), PEG volume was increased IO-fold.
b To further distance the ischemic interval from the anesthesia of preparative sur gery.
C Became unnecessary because the middle cerebral/common carotid artery occlu sion procedure could be completed within 20-30 min under light halothane anesthe sia.
expedite blood pressure recovery and awakening. All sur gical wounds were treated with 5% lidocaine ointment and closed.
WI and W2 animals began spontaneous respirations immediately upon extubation (-10 min after discontinu ing halothane). Approximately 15 min after halothane was discontinued, the animals awoke, were returned to their cages, and were given access to water.
Physiological monitoring
During MCAICCAO surgery, MABP was recorded continuously (Beckman R 511 polygraph), arterial blood gases and pH were serially measured (Corning 158 pHI blood gas analyzer), and body temperature was kept at 37°C using a rectal thermistor coupled to a heating lamp (Yellow Springs Instruments, Yellow Springs, OH, U.S.A.). Physiological variables were checked again 2 h after MCNCCAO.
Histologic analysis
The quantitation of infarct volume using frozen sec tions employed the method of Brint et aI. (1988) . Twenty four hours after MCAICCAO, the animals were anesthe tized and decapitated. The brains were removed from the calvaria and frozen in Freon over dry ice. Coronal sec tions (20 f.Lm thick) were cut with a cryostat ( -25°C) at 400-f.Lm (WI, W2, Fl) or 500-f.Lm (all other groups) inter vals, dried on a hot plate (60°C), immersed in 90% ethanol for 10 min, and stained with hematoxylin and eosin. In farcted cortex, readily distinguishable from noninfarcted brain by its staining characteristics, was measured with a Quantimet 970 Image Analyzer (Cambridge Instruments). All sectional infarct areas were then multiplied by the interval thickness and summed to yield the total infarct volume (mm3).
The Alzet pump, its tubing, and connections were ex-amined post mortem to ensure the integrity and complete ness of drug delivery over 24 h.
Cortical edema volume
In the SHRI and 2 groups, each animal had its left (nonischemic) cortical volume subtracted from its right (ischemic) cortical volume to yield the volume of edema (using Quantimet Image Analysis as described above).
Statistical analysis
Infarct volumes and physiologic parameters are ex pressed as means ± SE. The Student t test (two tailed) was used to compare cortical infarct volumes (and edema) in nimodipine versus vehicle control animals. Since cortical infarct volume was markedly influenced by the rat strain (Brint et aI., 1988) , a two-way analysis of variance (ANOV A) was used to evaluate the effect of nimodipine independently of rat strain among the six se ries. A simple linear correlation program was employed to determine if MABP at the time of MCNCCAO and 2 h after MCNCCAO influenced the size of the infarct vol ume. Scatter diagrams were plotted, and correlation co efficients (r) were calculated.
RESULTS

Physiological variables
Nimodipine decreased the baseline MABP by 10-15% in awake nonhypertensive rats and by 23% in awake SHRs ( Table 2 ). The hypotension was fur ther aggravated by anesthesia, but the latter re solved rapidly after ischemia onset (i.e., MABP rose by 4-7 mm Hg 2 min after MCA/CCAO). A mild, transient respiratory acidosis occurred in the nonventilated animals. Physiologic variables were otherwise comparable between nimodipine-treated animals and controls at every measured interval. The body temperature measured � 37.soC for both nimodipine and vehicle animals. Animals awoke 10--15 min after MCA/CCAO and showed drinking and grooming behavior 2 h later. Neurologic deficits 24 h later were subtle and found predominantly in SHRs (�50%). These included a preference for left turning when held by the tail, splaying of the left forelimb, and delayed righting when gently rolled onto the left side.
Reduction of infarct volume and edema by nimodipine
Nimodipine-treated animals developed smaller mean infarct volumes than controls in all experi mental groups (Table 3) . WI-3 and FI animals, however, exhibited considerable intergroup and in teranimal variability in infarct volume (reflected in the large standard errors) that could not be ex plained by alterations in physiologic variables or by technical aspects of the surgery (all were reviewed in detail). In a separate study, this variability was found to depend on animal strain, the supplier, and individual batches of animals (Brint et aI., 1988) . Because of this marked variability, the number of animals (see Table 3 ) in each nonhypertensive group alone was insufficient to yield statistical sig nificance by a Student t test. Analysis by a two-way ANOVA, however, yielded a p value of 0.047 for a nimodipine treatment effect. A Student t test of the SHRs (SHRI and 2 combined) yielded a p value of 0.004 for a nimodipine treatment effect (Table 4) . When all six groups were assessed by two-way ANOV A, the nimodipine effect was found to be highly significant (p = 0.0025), as was the indepen dent influence of experimental grouping (i.e., the influence of rat strain and different shipments of rats over time; p < 0.00001).
Edema represented � 36% of the infarct volume in SHRs in both nimodipine-and vehicle-treated groups, and its decrease by nimodipine was highly significant (p = 0.002) ( Table 4) . A scatter plot of individual edema and infarct volume measurements (mm3) suggests that the amount of edema is directly proportional to infarct size for both nimodipine treated (r = 0.90) and control (r = 0.90) animals ( Fig. 1) .
Effect of MABP on infarct volume
The MABP did not influence infarct volume in either the nimodipine-treated or the control groups. . Edema is linearly proportional to in farct volume in both groups (p < 0.001, two-tailed test). One nimodipine-treated animal was excluded from edema analy sis because the nonischemic hemisphere was lost during sectioning.
( Fig. 2) shows a typical distribution of infarct vol umes as a function of MABP (at the time of MCAI CCAO in nimodipine-and vehicle-treated SHRs). A lower MABP did not result in larger infarcts, nor did a higher MABP predispose to smaller infarcts. The rapid improvement in MABP upon discontinu ation of halothane immediately after MCA/CCAO may have prevented a more deleterious effect of hypotension. Despite persistent mild hypotension, the nimodipine-treated animals developed smaller infarcts than controls.
DISCUSSION
The data indicate that continuous nimodipine treatment, initiated prior to ischemia, reduces cor tical infarct volume in awake animals 24 h after per manent MCA/CCAO. Cortical edema falls in direct proportion to the decrease in infarct size. Nimo dipine induces hypotension, but it is mild and with out adverse effect. Animals benefit regardless of strain, suggesting that even a relative paucity of vascular collaterals, as occurs in the SHR strain (Johannson and Nordborg, 1978; Coyle, 1986; Brint et aI., 1988) , does not countermand protection against infarction.
Nimodipine salvaged �25% of ischemic cortex at risk for infarction in untreated hypertensive rats (between 20 and 60% in normotensive animals). The precise degree of conferred protection is uncertain, since interanimal infarct volume varied consider ably in both treated and untreated normotensive an imals. While the model was being standardized, it was determined that the source of this variability in brain infarct volume was related to strain, supplier, and specific batches of animals rather than to the surgeon or to methodologic factors (Brint et aI., 1988) . These strain-dependent factors probably rep- No correlation exists between degree of hypotension and infarct size. A similar lack of correlation was found at 2 h after MCA/CCAO. resent genetic determinants of vascular collaterals that govern the ischemic density and topography after MCAO (Pay an et aI., 1965; Coyle and Joke lainen, 1982, 1983; Duverger et al., 1985; Brint et aI., 1988) .
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This variability in infarct size posed a major prob lem in the evaluation of nimodipine efficacy in nor motensive animals: Although a reduction in mean infarct volume was repeatedly observed with nimo dipine treatment, the interanimal infarct variability was too large (reflected in the large standard errors) and the number of animals per group too small to yield statistical significance by a Student t test. To conclude that efficacy was lacking, however, was to invite a Type II error (i.e., falsely concluding that no difference exists between treatment and control when, in fact, the sample size is too small to detect a true difference) [see Freiman et al. (1978) for an excellent review]. This problem was circumvented by testing for both a nimodipine treatment effect and a strain effect across the four nonhypertensive groups using a two-way ANOV A. This confirmed a strong strain influence (p < 0.0001) on infarct vol ume and an independent nimodipine treatment ef fect (p < 0.05).
The SHR was also subject to variability in infarct production, although less so than the normotensive rat (Brint et al., 1988) . In a preliminary report (Jacewicz et aI., 1987) , we suggested that nimo dipine was of no benefit, but in retrospect, because of the small number of animals tested at that time (six treated with nimodipine), a Type II error can not be excluded. The subsequently expanded series (SHRl) produced a trend toward infarct reduction (p = 0.09, Student's t test) that became statistically significant (p = 0.004) when still more animals were tested (SHRI and 2). A power analysis (Brint et aI., 1988) subsequently projected a sample size of 8-31 hypertensive rats needed per group (depending on the selected operative group) to detect a 25% reduc tion (80% power at the 0.05 level of significance, 13 = 0.2, (l = 0.05). These experiments underscore the capricious influence of strain on focal stroke models and emphasize the need for adequate sam ple size and suitable statistical methods in designing drug studies (Freiman et aI., 1978; Pulsinelli and Buchan, 1989) .
The reduction in cerebral edema by nimodipine treatment was directly proportional to the decrease in infarct volume. By 24 h after MCAICCAO, �36% of any infarct volume, large or small, was due to edema in both nimodipine-treated and control SHRs. This indicates that nimodipine did not re duce infarct volume through an osmotic effect (e.g., as might occur with mannitol treatment). Further-more, nimodipine did not cause a greater accumu lation of edema, a potential adverse effect of im proved CBF in ischemic brain (Harris et aI., 1982) . A similar volume of edema may accumulate as early as 6 h after MCAO (Hadani et aI., 1988) . In a related study (M. Jacewicz et aI., in preparation) , we have shown that edema accumulates less rapidly in ni modipine-pretreated SHRs than in controls (i.e., 26% of the final edema volume is present 2.5 h after MCA/CCAO v. 39% in controls). This suggests that cortex, destined to infarct despite nimodipine treat ment, may nevertheless become damaged more slowly in the early hours after ischemia's onset. If, in addition to preventing infarction, nimodipine also delays the infarct process, then additional early measures (e.g., reversal of ischemia by throm bolytic therapy) could potentially salvage even more cortex.
The mild hypotensive effect of nimodipine did not provoke larger infarcts when compared with con trols. This is consistent with other experimental (Mohamed et aI., 1985a,b; Meyer et aI., 1986) and clinical (Allen et aI., 1983; Auer, 1984; Philippon et aI., 1986; Brandt et aI., 1988; Gelmers et aI., 1988; Ohman and Heiskanen, 1988; Petruk et aI., 1988) studies that have determined nimodipine in thera peutic doses causes only modest hypotension that is of no clinical significance. This finding is important, since, with increasing doses, nimodipine-induced hypotension may offset the rise in CBF (Mohamed et aI., 1984) . More surprisingly, in this study, the infarct size did not correlate with blood pressure (measured at onset of ischemia and 2 h later) in either the nimodipine-treated animals or the con trols. Within a treatment or control group, animals that had relatively lower blood pressures developed a range of infarct volumes that were indistinguish able from those of cohorts with higher blood pres sures. Since cerebral ischemia impairs autoregula tion (Ledingham and Rajagopalan, 1979; Kontos, 1986) , an independent influence of blood pressure on infarct size had been anticipated. The rapid re covery of blood pressure to alert levels after onset of ischemia, however, may have minimized the po tentially deleterious effects of halothane and nimo dipine on cerebral perfusion pressure. Alterna tively, some interanimal trait other than blood pres sure may have had an overriding influence in determining residual perfusion (e.g., availability of vascular collaterals) or in otherwise protecting brain that had lost its autoregulation of CBF.
The mechanism by which nimodipine attentuates brain infarction in the current paradigm involves, at least in part, a nimodipine-mediated increase in re sidual CBF in the ischemic bed (M. Jacewicz et aI., J Cereb Blood Flow Metab, Vol. 10, No. 1, 1990 in preparation). The MCA/CCAO model features focal, graded ischemia over extensive regions of neocortex (Jacewicz et aI., 1986; Brint et aI., 1988; M. J acewicz et aI., in preparation) . The infarct pro cess begins anteriorly in a densely ischemic core and evolves over a period of at least 4 h to include more peripheral regions of the MCA territory (Brint et aI., 1987) . At 2.5 h after MCA/CCAO, extensive regions of the cortex are undergoing progressive ir reversible injury, and CBF measurements (M. Jacewicz et aI., in preparation) demonstrate that ni modi pine-treated animals suffer considerably less ischemia than controls; in fact, they have a 50% smaller "ischemic core" (i.e., volume of cortex with CBF of <25 mlll00 g/min, a level of blood flow associated with early irreversible damage) (Tyson et aI., 1984) . Whether the salutary effect on CBF lasts for 24 h is not known, and other mechanisms, such as direct neuronal calcium antagonism (Miller, 1987; Scriabine and van den Kerckhoff, 1988) , could contribute to nimodipine's protective effect against ischemic damage (Hakim, 1986; Meyer et aI., 1986; Siesjo, 1986; Hakim, 1988, 1989) .
Previous studies have also found improved CBF and cellular protection with nimodipine pretreat ment (Mohamed et aI., 1985a; Meyer et aI., 1988) . These reports, however, may not apply to awake animals because general anesthesia may have sig nificantly contributed to the CBF increases (Kanda and Flaim, 1986) , perhaps by opening the blood brain barrier to nimodipine (Harper et aI., 1981; Scriabine et aI., 1985) . Anesthesia (e.g., halothane) can also cause hypotension (Keaney et aI., 1973) , induce respiratory acidosis (if the animal is not me chanically ventilated), disturb cerebral autoregula tion (Forster et aI., 1978; Hickey et aI., 1988) , open the blood-brain barrier (Forster et aI., 1978) , de press cerebral O2 consumption (Morita et aI., 1977) and energy metabolism (Michenfelder and Theye, 1975) , and increase CBF in both ischemic and nonischemic structures (McDowall, 1967; Smith et aI., 1973; Anderson et aI., 1980) . These side-effects of anesthesia can seriously complicate the interpre tation and clinical relevance of experimental stroke studies, especially when evaluating drug therapy. For these reasons, the current study was designed to minimize overlap between anesthesia exposure and the ischemic interval. It is the first study to document long-term protection by nimodipine pre treatment of neocortex against focal cerebral isch emia in awake animals.
Pretreatment with nimodipine may appear im practical since most acute strokes occur without warning. Nonetheless, there are clinical settings (e.g., subarachnoid hemorrhage, "crescendo tran sient ischemic attacks," dural sinus thrombosis, bacterial endocarditis, infected cardiac valvular prostheses, and open-heart surgery) that are com monly complicated by cerebral ischemia. In these patients, pretreatment with nimodipine is feasible and deserves further study.
